Abstract
Ch4 neurons were studied morphometrically in three normal controls and three patients with Alzheimer’s disease (AD). Two series of preparations stained with cresyl violet and with the indirect immunoperoxidase method using a monoclonal antibody to acetylcholinesterase (AChE) counterstained with cresyl violet were morphometrically analyzed. The cholinergic neurons were identified as positive reaction products of AChE in the perikarya. The cross-sectional area of all the Ch4 neurons with clearly visible nucleoli in one preparation was measured using a computer imaging system. Evaluation of these data provided a mean value of the cross-sectional neuronal area (CNA), number of neurons, standard deviation of the CNA and coefficient of variation of the cholinergic and noncholinergic neurons. The cholinergic neurons were decreased in number but showed hypertrophy in the early stage of AD, and they gradually became atrophic in the advanced stage. The noncholinergic neurons showed only atrophy without definite neuronal cell depletion. These findings indicate that cholinergic neurons have a plasticity and remodeling property against the AD process and suggest that hypertrophy of the cholinergic neurons in the Ch4 is the result of the effect of neurotrophic factors.
Article PDF
Similar content being viewed by others
References
Allen S. J., Dawbaron D., and Wilcock G. K. (1988) Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer’s disease.Brain Res. 454, 275A-281A.
Appel S. H. (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism and Alzheimer’s disease.Ann. Neurol. 10, 499A-505A.
Atterwill C. K. and Bowen D. M. (1986) Neurotrophic factor for central cholinergic neurones is present in both normal and Alzheimer brain tissue.Acta Neuropathol. 69, 341A-342A.
Chan-Palay V. (1988) Galanin hyperinnervates surviving neruons of the human basal nucleus of Meynert in dementias of Alzheimer’s and Parkinson’s disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.J. Comp. Neurol. 273, 543A-557A.
Fukutani Y., Nakamura I., Kobayashi K., Yamaguchi N., and Matsubara R. (1988) An autopsy case of familiar juvenile Alzheimer’s disease with extensive involvement of the subcorical grey matter and white matter.Acta Neuropathol. 77, 329A-332A.
Gnahn H., Hefti F., Heumann R., Schwab M. E., and Thoenen H. (1983) NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat brain: evidence for a physiological role of NGF in the brain?Dev. Brain Res. 9, 45A-52A.
Hefti F. (1983) Is Alzheimer’s disease caused by lack of nerve growth factor?Ann. Neurol. 13, 109A-110A.
Hefti F., Hartikka J., Eckenstein F., Gnahn H., Heumann R., and Schwab M. (1985) Nerve growth factor (NGF) increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons.Neuroscience 14, 55A-68A.
Hefti F., Hartikka J., Salvatierra A., Weiner W. J., and Mash D. C. (1986) Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain.Neurosci. Lett. 69, 37A-41A.
Hirano A., and Zimmerman H. M. (1962) Alzheimer’s neurofibrillary changes. A topographic study.Arch. Neurol. 7, 227A-242A.
Kiyosawa M., Baron J. C., Hamel E., Pappata S., Duverger D., Riche D., Mazoyer B., Naquet R. and MacKenzie E. T. (1989) Time course of effects of unilateral lesions of the nucleus basalis of Meynert on glucose utilization by the cerebral cortex.Brain 112, 435A-455A.
Kobayashi K., Fukutani Y., Nakamura I., Kawasaki Y., Suzuki M., Yamaguchi N., and Nakanishi I. (1990) Morphometric study of the magnocellular basal forebrain system in patients with Alzheimer’s disease.Brain and Nerve 42, 345A-351A (Japanese).
Martinez H. J., Dreyfus C. F., Jonakait G. M., and Black I. B. (1987) Nerve growth factor selectively increases cholinergic markers but not neuropeptides in rat basal forebrain in culture.Brain Res. 412, 295A-301A.
Mesulam M. M., Mufson E. J., Levey A. I., and Wainer B. H. (1983a) Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.J. Comp. Neurol. 214, 170A-197A.
Mesulam M. M., Mufson E. J., Wainer B. H., and Levey A. I. (1983b) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).Neuroscience 10, 1185A-1201A.
Nagai T., McGeer P. L., Peng J. H., MacGeer E. G., and Dolman C. E. (1983) Choline acetyltransferase immunohistochemistry in brains of Alzheimer’s disease patients and controls.Neurosci. Lett. 36, 195A-199A.
Nakano I. and Hirano A. (1985) Senile dementia and nucleus basalis of Meynert.Shinkei Kenkyu no Shinpo 29, 612A-623A (Japanese).
Pearson R. C. A., Sofroniew M. V., and Powell T. P. S. (1987) The cholinergic nucleic of the basal forebrain of the rat: Hypertrophy following contralateral cortical damage or section of the corpus collosum.Brain Res. 411, 332A-340A.
Perry E. K. and Perry R. H. (1983) Acetylcholinesterase in Alzheimer’s disease, inAlzheimer’s disease (Reisberg B., ed.), pp. 93–99, Collier Macmillan, London.
Rieger F., Shelanski M. L., and Greene L. A. (1980) The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: Increased total specific activity and appearance of the 16S molecular form.Dev. Biol. 76, 238A-243A.
Vogels O. J. M., Renkawek K., Broere C. A. J., ter Laak H. J., and van Workum F. (1989) Galanin-like immunoreactivity within Ch2 neurons in the vertical limb of the diagonal bond of Broca in aging with Alzheimer’s disease.Acta Neuropathol. 78, 90A-95A.
Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., and Delong M. R. (1982) Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain.Science 215, 1237A-1239A.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobayashi, K., Miyazu, K., Fukutani, Y. et al. Morphometric study on the CH4 of the nucleus basalis of meynert in Alzheimer’s disease. Molecular and Chemical Neuropathology 15, 193–206 (1991). https://doi.org/10.1007/BF03161059
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03161059